These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 31336501)
1. A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting. Rashid F; Abdelgadir E Diabetes Metab Syndr; 2019; 13(2):1413-1429. PubMed ID: 31336501 [TBL] [Abstract][Full Text] [Related]
2. Diabetes and Ramadan: an update on use of glycemic therapies during fasting. Ahmed MH; Abdu TA Ann Saudi Med; 2011; 31(4):402-6. PubMed ID: 21727749 [TBL] [Abstract][Full Text] [Related]
3. Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies. Lee SWH; Lee JY; Tan CSS; Wong CP Medicine (Baltimore); 2016 Jan; 95(2):e2457. PubMed ID: 26765440 [TBL] [Abstract][Full Text] [Related]
4. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait. Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694 [TBL] [Abstract][Full Text] [Related]
5. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Kobeissy A; Zantout MS; Azar ST Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984 [TBL] [Abstract][Full Text] [Related]
6. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach. Mbanya JC; Al-Sifri S; Abdel-Rahim A; Satman I Diabetes Res Clin Pract; 2015 Aug; 109(2):226-32. PubMed ID: 26003888 [TBL] [Abstract][Full Text] [Related]
7. Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis. Shiju R; Akhil A; Thankachan S; Tuomilehto J; Al Arouj M; Bennakhi A J Diabetes Res; 2022; 2022():3846253. PubMed ID: 35242880 [TBL] [Abstract][Full Text] [Related]
8. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes. Abdelgadir E; Rashid F; Bashier A; Al Saeed M; Khalifa A; Alawadi F; Hassanein M Diabetes Metab Syndr; 2019; 13(5):2927-2932. PubMed ID: 31425958 [TBL] [Abstract][Full Text] [Related]
9. Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan. Loh HH; Kamaruddin NA Ann Acad Med Singap; 2020 Jul; 49(7):468-476. PubMed ID: 33000110 [TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801 [TBL] [Abstract][Full Text] [Related]
11. Clinical practice points for diabetes management during RAMADAN fast. Sadikot S; Jothydev K; Zargar AH; Ahmad J; Arvind SR; Saboo B Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S811-S819. PubMed ID: 28629656 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
13. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus. Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366 [TBL] [Abstract][Full Text] [Related]
14. Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies. Abdelrahim D; Faris ME; Hassanein M; Shakir AZ; Yusuf AM; Almeneessier AS; BaHammam AS Front Endocrinol (Lausanne); 2021; 12():624423. PubMed ID: 33763029 [TBL] [Abstract][Full Text] [Related]
15. A systematic review on the safety of Ramadan fasting in high-risk patients with Diabetes. Rashid F; Abdelgadir E; Bashier A Diabetes Res Clin Pract; 2020 Jun; 164():108161. PubMed ID: 32335095 [TBL] [Abstract][Full Text] [Related]
16. Attitude and safety of patients with diabetes observing the Ramadan fast. Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851 [TBL] [Abstract][Full Text] [Related]
17. [Diabetes and Ramadan]. Ahdi M; Malki F; van Oosten W; Gerdes VE; Meesters EW Ned Tijdschr Geneeskd; 2008 Aug; 152(34):1871-4. PubMed ID: 18788677 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis. Gad H; Hayat T; Al-Muhannadi H; Malik BR; Mussleman P; Malik RA Diabetes Res Clin Pract; 2021 Feb; 172():108562. PubMed ID: 33271228 [TBL] [Abstract][Full Text] [Related]
19. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review. Alabbood MH; Ho KW; Simons MR Diabetes Metab Syndr; 2017; 11(1):83-87. PubMed ID: 27402028 [TBL] [Abstract][Full Text] [Related]
20. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia. Aziz KM Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]